As part of our process of continuously keeping the Neurochecklists database current, please see below some of our almost 3,700 checklists that we recently updated.

The revision used the latest in the neurology literature which you will find in the detailed references accompanying each checklist.

Aadrenoleukodystrophy (ALD): management

Agrypnia excitata

Alzheimer’s disease (AD): emerging investigations

Alzheimer’s disease (AD): protective factors

Alzheimer’s disease (AD): risk factors

Ataxia telangiectasia (AT)

Balint’s syndrome

Behcet’s syndrome: management

Biotidinase deficiency: clinical features

Brachial neuritis: investigations

Cerebral amyloid angiopathy (CAA): haemorrhage types

Cerebral amyloid angiopathy (CAA): clinical features

Cerebral aneurysms: clinical features

Cerebral aneurysms: risk factors

Cerebral vein thrombosis (CVT): risk factors

CGRP agonists

CIDP: investigations

CIDP: immunosuppressant treatment 

Cluster headache (CH): causes

Cluster headache (CH): clinical features

Corticobasal syndrome (CBS): clinical features

Distal hereditary motor neuropathy (hDMN): genetics

DPPX autoimmune encephalitis

Duchenne muscular dystrophy (DMD): treatment

Epicrania fugax

Epilepsy and autoimmune disorders

Epilepsy surgery

Epilepsy with eyelid myoclonia

Epileptic encephalopathy: classification

Episodic ataxia: summary checklist

Familial CJD

Frontotemporal brain sagging syndrome (FBSS)

Frontotemporal dementia (FTD): differential diagnosis

Frontotemporal dementia (FTD): management

Functional cognitive disorder

Functional seizures: complications

GFAP encephalitis: management

Huntington’s disease (HD): clinical features

Huntington’s disease (HD): treatment

Idiopathic intracranial hypertension (IIH): dural venous sinus stenting

Immune mediated necrotizing myopathy (IMNM): causes

Intracerebral haemorrhage (ICH): causes

LARS2 leukoencephalopathy

Laryngeal dystonia

Limbic predominant age-related TDP43 encephalopathy (LATE)

Lyme neuroborreliosis: clinical features

Malformations of cortical development (MCD): other genes

Mirror movements

Mitochondrial POLG disorders: management

MOG antibody disease: MRI features

Motor neurone disease (MND): clinical features

Motor neurone disease (MND): other genetic risk factors

Motor neurone disease (MND): investigational drug treatments

Motor neurone disease (MND): non-genetic risk factors

Multifocal motor neuropathy (MMN): clinical features

Multiple sclerosis (MS) and seizures

Multiple sclerosis (MS): breastfeeding in pregnancy

Multiple sclerosis (MS): modifiable risk factors

Multiple sclerosis (MS): poor prognostic factors

Myasthenia gravis (MG): triggers

Myotonic dystrophy and cancer

Myotonic dystrophy type 1: neurological features

Narcolepsy: secondary causes

Neuroangiostrongyliasis: management

Neurocysticercosis: pathology

Neurological guidelines directory

NMDAR antibody encephalitis: atypical features

NMDAR antibody encephalitis: investigations

Nodding syndrome: clinical features

Non-compressive myelopathy

Non-convulsive status epilepticus (NCSE): clinical features

Normal pressure hydrocephalus (NPH): clinical features

Ocrelizumab

Palatal tremor

Parkinson’s disease (PD): differential diagnosis

Parkinson’s disease (PD): protective factors

Parkinson’s disease (PD): systemic features

Parkinson’s disease (PD): systemic risk factors

Primary progressive aphasia non-fluent variant (NFVPPA)

Progressive multifocal leukoencephalopathy (PML): investigations

Progressive supranuclear palsy (PSP): clinical features

Rasmussen’s encephalopathy (RE): management

Reflex seizures

Refractory epilepsy: treatment

Rosai Dorfman disease (RDD): differential diagnosis

Spinocerebellar ataxia 3 (SCA 3): clinical features

Seizures: neurological features

SMART syndrome: management

Spastic paraparesis: causes

Spinocerebellar ataxia 27 (SCA 27)

Stiff person syndrome (SPS): investigational treatments

Stroke: investigational drugs

SUNCT: treatment

Systemic seizures: manifestations

Traumatic brain injury (TBI): complications

Tremors: medical causes

Triptans: adverse effects

Triptans: clinical use

Uraemic encephalopathy

West Nile virus (WNV) infection: management

Wilson’s disease: MRI features